Authored By: Sarah
24 Jun 2024

 Prefilled Syringes Market Size to grow by USD 4045.9 million between 2024-2028

According to a research report “ Prefilled Syringes Market” by Material (Glass pre-filled syringes, Plastic pre-filled syringes) Type (Disposable, Reusable) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 4045.9 million, at a CAGR of almost 9.45% during the forecast period. In the advanced healthcare markets of the US and Canada, regulatory frameworks prioritize the safety of healthcare professionals from needlestick injuries. Pre-filled syringes, outfitted with needle safety mechanisms, have gained significant traction due to their capability to mitigate such risks. Features such as automatic needle shielding and retractable needles are common offerings in the pre-filled syringe market. The Centers for Disease Control and Prevention (CDC) in the US advocates for the utilization of pre-filled syringes in immunization programs, owing to their time-saving benefits and extended vaccine potency and sterility during lengthy storage periods.

Browse market data tables, figures, and in-depth TOC on “Prefilled Syringes Market” by Material (Glass pre-filled syringes, Plastic pre-filled syringes) Type (Disposable, Reusable) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample

 

By Material, the Glass pre-filled syringes segment is projected to dominate the market size in 2024

The disposable pre-filled syringes market is projected to expand due to escalating concerns over sanitation and safety from HAIs, increasing healthcare spending in developing countries, and the rising prevalence of chronic diseases. However, the environmental impact of disposable syringes is driving the adoption of reusable pre-filled syringes, potentially curbing market growth during the forecast period. Keywords: disposable pre-filled syringes, market growth, sanitation, safety, healthcare spending, chronic diseases, reusable pre-filled syringes, environmental impact.

By Type, Disposable  segment is expected to hold the largest market size for the year 2024

In the Prefilled Syringes Market, glass pre-filled syringes are poised for substantial expansion. Regulatory simplicity, broad acceptance among consumers, and a larger drug inventory compared to plastic alternatives are key drivers. The glass pre-filled syringe, a disposable device with a glass barrel containing drugs or biologics, is the industry standard. Its popularity stems from its long-standing use and suitability for parenteral drugs due to its non-reactive and stable nature, as well as its oxygen permeability, addressing the needs of oxygen-sensitive drugs like morphine.

North America is forecasted to hold the largest market size by region in 2024

The Prefilled Syringes Market represents a significant business opportunity, driven by the increasing demand for convenient and efficient drug delivery systems. These syringes, pre-loaded with a precise dose of medication, offer advantages such as reduced administration errors and improved patient compliance. Key market trends include technological advancements, regulatory approvals, and growing applications in various therapeutic areas.

The Prefilled Syringes Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Ajinomoto Bio Pharma Services
  • ApiJect Systems Corp.
  • AptarGroup Inc.
  • Baxter International Inc.
  • Becton Dickinson and Co.
  • Catalent Inc.
  • Fresenius SE and Co. KGaA
  • Gerresheimer AG
  • Haselmeier GmbH
  • Nipro Corp.
  • Novartis AG
  • Owen Mumford Ltd.
  • Recipharm AB
  • SCHOTT AG
  • SHL Medical AG
  • STERINOVA
  • Terumo Corp.
  • Vetter Pharma Fertigung GmbH and Co. KG
  • Viatris Inc.
  • West Pharmaceutical Services Inc.
.

For insights on company offerings- Request a sample report!

Research Analysis Overview

In the healthcare sector, prefilled syringes have gained significant attention due to their role in delivering various injectable medications, including saline syringes, insulin, mRNA COVID-19 vaccines, biosimilars, and biologics. The market for prefilled syringes is driven by the increasing prevalence of chronic diseases such as oncological disorders, cardiovascular disorders, and autoimmune disorders like rheumatoid arthritis. These conditions necessitate frequent self-injections, making the convenience and ease of use offered by prefilled syringes a preferred choice for both healthcare professionals and patients. The market for prefilled syringes encompasses a wide range of applications, from conventional vials to self-injection devices. The annual cost burden associated with these conditions necessitates the development of cost-effective solutions, making prefilled syringes an attractive option. Partner analysis and drug candidates in the pipeline further underscore the potential growth in this market. Assumptions regarding the target disease population and assumptions about the impact of needlestick legislations on the market add to the complexity of the prefilled syringes market analysis. The market for prefilled syringes is not limited to insulin and vaccines but also extends to heart diseases and other injectable medications.

Market Research Overview

In the realm of healthcare, prefilled syringes have emerged as a significant solution for injectable medications, including mRNA COVID-19 vaccines, insulin, biosimilars, and biologics. These syringes come in various types, such as multi-chamber syringes, lubrication technology-enabled syringes, and safety syringes, including flush syringes. Prefilled syringes offer advantages like dose precision, convenient usage, and reduced risk of contamination. The market for prefilled syringes encompasses a wide range of applications, from hospital pharmacies and home care services to self-administering devices like pen injectors and autoinjectors. The target population includes patients with chronic diseases like oncological disorders, cardiovascular disorders, and autoimmune disorders. Prefilled syringes contribute to drug wastage reduction and API use optimization. They are available in various formats, including single-chamber prefilled syringes, glass prefilled syringes, and vials. The adoption of prefilled syringes is influenced by factors like healthcare provider preferences, drug candidates, and partner analysis. Global healthcare costs, medical inflation, and insufficient healthcare funding pose challenges to the widespread use of prefilled syringes. However, the availability of cheaper alternatives and the potential for needlestick legislations to drive demand offer opportunities for growth in this market.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!
Technavio
Document